Viva Biotech (688321.SH): Application for clinical trial of TheoLonide capsules in the treatment of metastatic pancreatic ductal adenocarcinoma has been accepted.

Wisdom Financial APP News, Weixin Bio (688321.SH) Announcement, the company recently received the "Acceptance Notice" for domestic drug registration clinical trials issued by the National Medical Products Administration Drug Evaluation Center. The company's self-developed drug Xioloni Capsules for the treatment of metastatic pancreatic ductal adenocarcinoma has been accepted for clinical trial application.